Growth Metrics

Gyre Therapeutics (GYRE) Other Working Capital Changes (2016 - 2026)

Gyre Therapeutics has reported Other Working Capital Changes over the past 16 years, most recently at $509000.0 for Q4 2025.

  • Quarterly Other Working Capital Changes rose 128.92% to $509000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $206000.0 through Dec 2025, up 795.65% year-over-year, with the annual reading at $10945.0 for FY2025, 52.41% down from the prior year.
  • Other Working Capital Changes was $509000.0 for Q4 2025 at Gyre Therapeutics, up from -$31000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $5.5 million in Q1 2025 and troughed at -$5.8 million in Q2 2025.
  • The 5-year median for Other Working Capital Changes is $13451.5 (2023), against an average of -$242677.3.
  • Year-over-year, Other Working Capital Changes skyrocketed 12418.48% in 2024 and then tumbled 9182.81% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$2.8 million in 2021, then soared by 72.98% to -$743000.0 in 2022, then tumbled by 51.01% to -$1.1 million in 2023, then crashed by 56.86% to -$1.8 million in 2024, then skyrocketed by 128.92% to $509000.0 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Other Working Capital Changes are $509000.0 (Q4 2025), -$31000.0 (Q3 2025), and -$5.8 million (Q2 2025).